Cargando…
THU535 Anti-angiogenic Multi-kinase Inhibitor In NUTM1 Rearranged Carcinoma Of Thyroid
Disclosure: S. Tella: None. J.C. Morris: None. M. Rivera: None. S. Gupta: None. M.M. Ryder: None. Introduction: NUT carcinoma is a rare subtype of squamous cell carcinoma defined by NUTM1 rearrangements encoding NUT-fusion oncoproteins with a very dismal prognosis. Recent data showed that NUTM1 rear...
Autores principales: | Tella, Sri Harsha, Morris, John C, Rivera, Michael, Gupta, Sounak, Ryder, Mabel M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555030/ http://dx.doi.org/10.1210/jendso/bvad114.2162 |
Ejemplares similares
-
RARE-38. CLINICAL PRESENTATION OF MGA-NUTM1 FUSION TRANSCRIPT SARCOMA
por: Pongphitcha, Pongpak, et al.
Publicado: (2020) -
Brain tumor with an ATXN1-NUTM1 fusion gene expands the histologic spectrum of NUTM1-rearranged neoplasia
por: Siegfried, Aurore, et al.
Publicado: (2019) -
THU484 Distinct Genetic Characteristics In Follicular Thyroid Cancer With Different Metastatic Potentials
por: Kwak, Soo-jung, et al.
Publicado: (2023) -
THU478 Unchecked Kinase Activation Underlies Pituitary Adenomas Causing Cushing’s Disease
por: Asuzu, David, et al.
Publicado: (2023) -
THU510 The Frequency Of Mutations In Advanced Thyroid Cancer In Japan: A Real Clinical Setting
por: Toda, Soji, et al.
Publicado: (2023)